Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Rocco

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of the American Society of Nephrology : JASN|June 1, 1996
Risk factors for hospital utilization in chronic dialysis patients. Southeastern Kidney Council (Network 6)M V Rocco, J M Soucie, D M Reboussin, et al.
American Journal of Nephrology|August 18, 2001
Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO studyM V Rocco, G Yan, R J Heyka, et al.
Kidney International|May 7, 1999
Cycler adequacy and prescription data in a national cohort sample: the 1997 core indicators report. Health Care Financing Administration Peritoneal Dialysis Core Indicators Study GroupM V Rocco, M J Flanigan, B Prowant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 1999
Erythropoietin and iron use in peritoneal dialysis patients. Report from the 1997 HCFA end-stage renal disease core indicators projectG R Bailie, D L Frankenfield, B F Prowant, et al.
American Journal of Therapeutics|September 1, 1996
Effects of Terazosin on Glycemic Control, Cholesterol, and Microalbuminuria in Patients with Non--Insulin-Dependent Diabetes Mellitus and HypertensionJ. K. Kirk, J. C. Konen, Z. Shihabi, et al.
Kidney International|December 12, 2001
Clinical performance measures: the changing status of peritoneal dialysisM J Flanigan, M V Rocco, B Prowant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 3, 2000
Impact of facility size and profit status on intermediate outcomes in chronic dialysis patientsD L Frankenfield, J R Sugarman, R J Presley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 1999
1997 Peritoneal Dialysis-Core Indicators Study: Dialysis Adequacy and Nutritional Indicators ReportM J Flanigan, M V Rocco, D Frankenfield, et al.
Kidney International|January 29, 2000
Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators ProjectD Frankenfield, C A Johnson, J B Wish, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 18, 2000
Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators WorkgroupM V Rocco, D L Frankenfield, P R Frederick, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of the American Society of Nephrology : JASN|June 1, 1996
Risk factors for hospital utilization in chronic dialysis patients. Southeastern Kidney Council (Network 6)M V Rocco, J M Soucie, D M Reboussin, et al.
American Journal of Nephrology|August 18, 2001
Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO studyM V Rocco, G Yan, R J Heyka, et al.
Kidney International|May 7, 1999
Cycler adequacy and prescription data in a national cohort sample: the 1997 core indicators report. Health Care Financing Administration Peritoneal Dialysis Core Indicators Study GroupM V Rocco, M J Flanigan, B Prowant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 1999
Erythropoietin and iron use in peritoneal dialysis patients. Report from the 1997 HCFA end-stage renal disease core indicators projectG R Bailie, D L Frankenfield, B F Prowant, et al.
American Journal of Therapeutics|September 1, 1996
Effects of Terazosin on Glycemic Control, Cholesterol, and Microalbuminuria in Patients with Non--Insulin-Dependent Diabetes Mellitus and HypertensionJ. K. Kirk, J. C. Konen, Z. Shihabi, et al.
Kidney International|December 12, 2001
Clinical performance measures: the changing status of peritoneal dialysisM J Flanigan, M V Rocco, B Prowant, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 3, 2000
Impact of facility size and profit status on intermediate outcomes in chronic dialysis patientsD L Frankenfield, J R Sugarman, R J Presley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 1999
1997 Peritoneal Dialysis-Core Indicators Study: Dialysis Adequacy and Nutritional Indicators ReportM J Flanigan, M V Rocco, D Frankenfield, et al.
Kidney International|January 29, 2000
Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators ProjectD Frankenfield, C A Johnson, J B Wish, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 18, 2000
Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators WorkgroupM V Rocco, D L Frankenfield, P R Frederick, et al.
Pageof 5